N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.Wolfgang Wick, Lisa-Marie Lanz,Antje Wick,Inga Harting,Susan Dettmer,Abigail k Suwala,Ralf Ketter,Ghazaleh Tabatabai, Corinna Seliger-Behme,Martin Glas,Michael C Burger,Marco Timmer,Florian A Ringel,Iris Mildenberger,Walter J Schulz-Schaeffer,Mirjam Renovanz,Martin Bendszus,Felix Sahm,Michael Platten,Tobias KesslerJournal of Clinical Oncology（2024）引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
